Deep Learning of the Retina Enables Phenome- and Genome-Wide Analyses of the Microvasculature.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
11 01 2022
Historique:
pubmed: 9 11 2021
medline: 23 2 2022
entrez: 8 11 2021
Statut: ppublish

Résumé

The microvasculature, the smallest blood vessels in the body, has key roles in maintenance of organ health and tumorigenesis. The retinal fundus is a window for human in vivo noninvasive assessment of the microvasculature. Large-scale complementary machine learning-based assessment of the retinal vasculature with phenome-wide and genome-wide analyses may yield new insights into human health and disease. We used 97 895 retinal fundus images from 54 813 UK Biobank participants. Using convolutional neural networks to segment the retinal microvasculature, we calculated vascular density and fractal dimension as a measure of vascular branching complexity. We associated these indices with 1866 incident Low retinal vascular fractal dimension and density were significantly associated with higher risks for incident mortality, hypertension, congestive heart failure, renal failure, type 2 diabetes, sleep apnea, anemia, and multiple ocular conditions, as well as corresponding quantitative traits. Genome-wide association of vascular fractal dimension and density identified 7 and 13 novel loci, respectively, that were enriched for pathways linked to angiogenesis (eg, vascular endothelial growth factor, platelet-derived growth factor receptor, angiopoietin, and WNT signaling pathways) and inflammation (eg, interleukin, cytokine signaling). Our results indicate that the retinal vasculature may serve as a biomarker for future cardiometabolic and ocular disease and provide insights into genes and biological pathways influencing microvascular indices. Moreover, such a framework highlights how deep learning of images can quantify an interpretable phenotype for integration with electronic health record, biomarker, and genetic data to inform risk prediction and risk modification.

Sections du résumé

BACKGROUND
The microvasculature, the smallest blood vessels in the body, has key roles in maintenance of organ health and tumorigenesis. The retinal fundus is a window for human in vivo noninvasive assessment of the microvasculature. Large-scale complementary machine learning-based assessment of the retinal vasculature with phenome-wide and genome-wide analyses may yield new insights into human health and disease.
METHODS
We used 97 895 retinal fundus images from 54 813 UK Biobank participants. Using convolutional neural networks to segment the retinal microvasculature, we calculated vascular density and fractal dimension as a measure of vascular branching complexity. We associated these indices with 1866 incident
RESULTS
Low retinal vascular fractal dimension and density were significantly associated with higher risks for incident mortality, hypertension, congestive heart failure, renal failure, type 2 diabetes, sleep apnea, anemia, and multiple ocular conditions, as well as corresponding quantitative traits. Genome-wide association of vascular fractal dimension and density identified 7 and 13 novel loci, respectively, that were enriched for pathways linked to angiogenesis (eg, vascular endothelial growth factor, platelet-derived growth factor receptor, angiopoietin, and WNT signaling pathways) and inflammation (eg, interleukin, cytokine signaling).
CONCLUSIONS
Our results indicate that the retinal vasculature may serve as a biomarker for future cardiometabolic and ocular disease and provide insights into genes and biological pathways influencing microvascular indices. Moreover, such a framework highlights how deep learning of images can quantify an interpretable phenotype for integration with electronic health record, biomarker, and genetic data to inform risk prediction and risk modification.

Identifiants

pubmed: 34743558
doi: 10.1161/CIRCULATIONAHA.121.057709
pmc: PMC8746912
mid: NIHMS1759615
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

134-150

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_1605/13
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL151283
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL127564
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL142711
Pays : United States
Organisme : British Heart Foundation
ID : RG/19/6/34387
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/18/4/34215
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL148050
Pays : United States
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : British Heart Foundation
ID : NH/17/1/32725
Pays : United Kingdom
Organisme : NEI NIH HHS
ID : K23 EY032634
Pays : United States

Références

PLoS Genet. 2010 Oct 28;6(10):e1001184
pubmed: 21060863
N Engl J Med. 2012 Mar 29;366(13):1227-39
pubmed: 22455417
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
IEEE Trans Biomed Eng. 2012 Sep;59(9):2538-48
pubmed: 22736688
J Am Heart Assoc. 2019 Feb 5;8(3):e011104
pubmed: 30712442
IEEE Trans Med Imaging. 2000 Mar;19(3):203-10
pubmed: 10875704
Bioinformatics. 2016 May 15;32(10):1493-501
pubmed: 26773131
Am J Cardiol. 2008 Jul 1;102(1):58-63
pubmed: 18572036
PLoS One. 2013 Jun 12;8(6):e65804
pubmed: 23776548
Neurology. 2011 May 17;76(20):1766-7
pubmed: 21576694
Pigment Cell Res. 1997 Feb-Apr;10(1-2):25-33
pubmed: 9170159
Med Image Anal. 2015 Jan;19(1):46-57
pubmed: 25240643
Lancet. 2007 Feb 3;369(9559):425-35
pubmed: 17276782
Nat Genet. 2018 Jun;50(6):834-848
pubmed: 29808027
Diabetologia. 2018 Jan;61(1):29-38
pubmed: 28942458
Surv Ophthalmol. 2009 Jan-Feb;54(1):74-95
pubmed: 19171211
Sci Rep. 2019 May 30;9(1):8060
pubmed: 31147610
Pharmacol Rev. 2018 Jan;70(1):68-141
pubmed: 29247129
Int J Epidemiol. 2003 Feb;32(1):1-22
pubmed: 12689998
PLoS One. 2020 Sep 23;15(9):e0238529
pubmed: 32966289
Neurology. 2005 Oct 11;65(7):1005-9
pubmed: 16217050
Cell Adh Migr. 2007 Apr-Jun;1(2):104-6
pubmed: 19329884
Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1253-1261
pubmed: 31070453
J Womens Health (Larchmt). 2020 Jun;29(6):770-779
pubmed: 32074468
Bioinformatics. 2010 May 1;26(9):1205-10
pubmed: 20335276
J Hum Genet. 2018 May;63(5):639-646
pubmed: 29531335
Nature. 2020 Aug;584(7822):589-594
pubmed: 32814899
PLoS One. 2013 Aug 05;8(8):e71239
pubmed: 23940728
J Burn Care Res. 2010 Jan-Feb;31(1):158-75
pubmed: 20061852
Neurology. 2010 Apr 6;74(14):1102-7
pubmed: 20368631
Ophthalmology. 2008 Nov;115(11):1951-6
pubmed: 18692247
PLoS One. 2012;7(3):e32435
pubmed: 22427837
J Alzheimers Dis. 2015;44(1):319-28
pubmed: 25213770
Clin Exp Ophthalmol. 2019 Mar;47(2):219-225
pubmed: 30203562
Am J Epidemiol. 1999 Aug 1;150(3):263-70
pubmed: 10430230
Sci Rep. 2020 Apr 16;10(1):6541
pubmed: 32300160
Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4714-8
pubmed: 17065478
Circulation. 2020 Aug 18;142(7):711-713
pubmed: 32804569
IEEE Trans Med Imaging. 2006 Dec;25(12):1531-46
pubmed: 17167990
IEEE Trans Med Imaging. 2006 Sep;25(9):1214-22
pubmed: 16967806
Eur Heart J. 2011 Feb;32(4):422-9
pubmed: 21138936
Curr Eye Res. 2002 Apr;24(4):274-80
pubmed: 12324866
Nat Genet. 2018 Aug;50(8):1161-1170
pubmed: 30038395
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W452-7
pubmed: 22689647
PLoS One. 2015 May 22;10(5):e0127914
pubmed: 26000792
Nat Genet. 1994 Nov;8(3):251-5
pubmed: 7874167
Arch Intern Med. 1979 Oct;139(10):1139-41
pubmed: 485746
Cytokine. 2019 Jun;118:3-7
pubmed: 30389232
Hypertension. 2012 Nov;60(5):1094-103
pubmed: 23045470
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
Hum Mol Genet. 2015 Apr 15;24(8):2125-37
pubmed: 25552646
JMIR Med Inform. 2019 Nov 29;7(4):e14325
pubmed: 31553307
Br J Ophthalmol. 2002 Sep;86(9):1007-13
pubmed: 12185128
Nat Genet. 2015 Nov;47(11):1228-35
pubmed: 26414678
Nat Genet. 2021 Jul;53(7):1097-1103
pubmed: 34017140
Cancers (Basel). 2019 Mar 06;11(3):
pubmed: 30845711
Ophthalmic Res. 2021;64(4):561-566
pubmed: 33454711
J Ophthalmol. 2016;2016:6259047
pubmed: 27703803
Am J Ophthalmol. 2012 Jan;153(1):176-83.e1
pubmed: 21907319
PLoS Genet. 2021 May 12;17(5):e1009497
pubmed: 33979322
Science. 2012 Feb 17;335(6070):823-8
pubmed: 22344438
Stroke. 2021 Apr;52(4):1276-1282
pubmed: 33611944
Med (N Y). 2021 Feb 12;2(2):137-148.e4
pubmed: 33283203
Am J Epidemiol. 2009 Dec 1;170(11):1323-32
pubmed: 19884126
Sci Rep. 2020 Oct 7;10(1):16718
pubmed: 33028913
Oncogene. 2012 May 10;31(19):2461-70
pubmed: 21996743
Biol Res. 2013;46(3):265-73
pubmed: 24346074
Ann Intern Med. 2009 Sep 15;151(6):404-13
pubmed: 19755365
Medicine (Baltimore). 2003 Jul;82(4):251-6
pubmed: 12861102
J Clin Sleep Med. 2017 Nov 15;13(11):1345-1348
pubmed: 28942764
Nat Genet. 2020 Apr;52(4):401-407
pubmed: 32231278
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
PLoS One. 2015 Apr 01;10(4):e0122332
pubmed: 25830353
N Engl J Med. 2011 May 19;364(20):1897-908
pubmed: 21526923
Diabetes Care. 2009 Jan;32(1):106-10
pubmed: 18835945
Am J Ophthalmol. 2012 Oct;154(4):663-674.e1
pubmed: 22840482
Comput Biol Med. 2016 Apr 1;71:67-76
pubmed: 26894596
Surv Ophthalmol. 1995 May;39 Suppl 1:S49-56
pubmed: 7660312
Sleep Med Rev. 2018 Apr;38:113-130
pubmed: 29107469
Neurology. 2006 May 9;66(9):1339-43
pubmed: 16682664
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5074-5081
pubmed: 30357402
Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20
pubmed: 23315928
J Am Coll Cardiol. 2018 Nov 27;72(21):2625-2641
pubmed: 30466521
Nature. 2020 Oct;586(7831):749-756
pubmed: 33087929
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2341-50
pubmed: 16723443
Microcirculation. 2007 Jan;14(1):25-38
pubmed: 17365659
Circ Genom Precis Med. 2019 Jun;12(6):e002453
pubmed: 31211625
BMJ Open Ophthalmol. 2017 Jul 11;1(1):e000032
pubmed: 29354699
Circ Cardiovasc Genet. 2016 Feb;9(1):45-54
pubmed: 26567291
N Engl J Med. 2015 Mar 26;372(13):1193-203
pubmed: 25692915
Ophthalmology. 2010 Jul;117(7):1400-5
pubmed: 20176399

Auteurs

Seyedeh Maryam Zekavat (SM)

Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, CT (S.M.Z., J.M., R.A.A., L.D.P., J.C.W.).
Computational Biology & Bioinformatics Program (S.M.Z., Y.Y., H.Z.), Yale University, New Haven, CT.
Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (S.M.Z., V.K.R., M.T., S.K., M.C.H., Z.Y., A.P., S.U., P.T.E., P.N.).

Vineet K Raghu (VK)

Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (S.M.Z., V.K.R., M.T., S.K., M.C.H., Z.Y., A.P., S.U., P.T.E., P.N.).
Cardiovascular Research Center (S.M.Z., V.K.R., M.C.H., S.U., S.H., P.T.E., P.N.), Massachusetts General Hospital, Harvard Medical School, Boston.
Cardiovascular Imaging Research Center (V.K.R.), Massachusetts General Hospital, Harvard Medical School, Boston.

Mark Trinder (M)

Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada (M.T.).

Yixuan Ye (Y)

Computational Biology & Bioinformatics Program (S.M.Z., Y.Y., H.Z.), Yale University, New Haven, CT.

Satoshi Koyama (S)

Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (S.M.Z., V.K.R., M.T., S.K., M.C.H., Z.Y., A.P., S.U., P.T.E., P.N.).

Michael C Honigberg (MC)

Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (S.M.Z., V.K.R., M.T., S.K., M.C.H., Z.Y., A.P., S.U., P.T.E., P.N.).
Cardiovascular Research Center (S.M.Z., V.K.R., M.C.H., S.U., S.H., P.T.E., P.N.), Massachusetts General Hospital, Harvard Medical School, Boston.

Zhi Yu (Z)

Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (S.M.Z., V.K.R., M.T., S.K., M.C.H., Z.Y., A.P., S.U., P.T.E., P.N.).

Akhil Pampana (A)

Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (S.M.Z., V.K.R., M.T., S.K., M.C.H., Z.Y., A.P., S.U., P.T.E., P.N.).

Sarah Urbut (S)

Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (S.M.Z., V.K.R., M.T., S.K., M.C.H., Z.Y., A.P., S.U., P.T.E., P.N.).
Cardiovascular Research Center (S.M.Z., V.K.R., M.C.H., S.U., S.H., P.T.E., P.N.), Massachusetts General Hospital, Harvard Medical School, Boston.

Sara Haidermota (S)

Cardiovascular Research Center (S.M.Z., V.K.R., M.C.H., S.U., S.H., P.T.E., P.N.), Massachusetts General Hospital, Harvard Medical School, Boston.

Declan P O'Regan (DP)

MRC London Institute of Medical Sciences, Imperial College London, UK (D.P.O.).

Hongyu Zhao (H)

Computational Biology & Bioinformatics Program (S.M.Z., Y.Y., H.Z.), Yale University, New Haven, CT.
School of Public Health (H.Z.), Yale University, New Haven, CT.

Patrick T Ellinor (PT)

Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (S.M.Z., V.K.R., M.T., S.K., M.C.H., Z.Y., A.P., S.U., P.T.E., P.N.).
Cardiovascular Research Center (S.M.Z., V.K.R., M.C.H., S.U., S.H., P.T.E., P.N.), Massachusetts General Hospital, Harvard Medical School, Boston.

Ayellet V Segrè (AV)

Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston (A.V.S., T.E., J.L.W., N.Z.).

Tobias Elze (T)

Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston (A.V.S., T.E., J.L.W., N.Z.).

Janey L Wiggs (JL)

Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston (A.V.S., T.E., J.L.W., N.Z.).

James Martone (J)

Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, CT (S.M.Z., J.M., R.A.A., L.D.P., J.C.W.).

Ron A Adelman (RA)

Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, CT (S.M.Z., J.M., R.A.A., L.D.P., J.C.W.).

Nazlee Zebardast (N)

Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston (A.V.S., T.E., J.L.W., N.Z.).

Lucian Del Priore (L)

Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, CT (S.M.Z., J.M., R.A.A., L.D.P., J.C.W.).

Jay C Wang (JC)

Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, CT (S.M.Z., J.M., R.A.A., L.D.P., J.C.W.).

Pradeep Natarajan (P)

Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (S.M.Z., V.K.R., M.T., S.K., M.C.H., Z.Y., A.P., S.U., P.T.E., P.N.).
Cardiovascular Research Center (S.M.Z., V.K.R., M.C.H., S.U., S.H., P.T.E., P.N.), Massachusetts General Hospital, Harvard Medical School, Boston.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH